Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid

Overview of attention for article published in BONE, December 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 4,777 followers.

Lezot et al: Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth http://t.co/jqtZ6WfXOV

Lezot et al: Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth ... http://t.co/56x76FQSAD

High onco-pediatric doses RANKL-blocking AB consequences on skeletal growth similar to ZOL injections in mice http://t.co/iyp8xstNIN

[Bone] Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain dispar... http://t.co/uQZdevQxj4

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.